Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virgin Instruments was a specialized life science instrumentation company focused on the development of advanced Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry technology. Founded by industry pioneer Marvin Vestal, the company aimed to improve the performance and accessibility of mass spectrometry for proteomics and clinical applications. Their innovations focused on increasing the speed and resolution of benchtop instruments, making high-end analytical capabilities more practical for research laboratories. In 2010, the company's technology and intellectual property were acquired by Shimadzu Corporation. This acquisition allowed Shimadzu to integrate Virgin Instruments' high-performance MALDI-TOF designs into its global product line, specifically enhancing its benchtop mass spectrometry offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Virgin Instruments.